The invention provides a composition useful in maintaining or improving mobility, preferably joint function and muscle strength in ageing, healthy subjects. The composition includes specific amounts of glucosamine or a pharmaceutically-acceptable derivative thereof, calcium, vitamin C, vitamin D and zinc. Also provided is the composition in the form of a powdered food product, and a beverage product comprising the composition in the form of a powder which has been reconstituted in a liquid. Also provided is the use of the composition or food or beverage product in maintaining or improving mobility, preferably joint function and muscle strength in ageing, healthy subjects.

A beverage nucleator system for a supercooled beverage container may include a frame for receiving a beverage container and an ultrasonic device positioned therein. The frame may include a beverage container aperture therein sized to allow direct contact between an ultrasonic transmitter coupled to the ultrasonic device and a closure on the container. The ultrasonic transmitter may operate at a 28 kHz frequency with a power of 5 W for 1-5 seconds. The beverage nucleator system provides for consistent nucleation of supercooled beverages without requiring a fluid or gel transmission medium.

A beverage nucleator system for a supercooled beverage container may include a frame for receiving a beverage container and an ultrasonic device positioned therein. The frame may include a beverage container aperture therein sized to allow direct contact between an ultrasonic transmitter coupled to the ultrasonic device and a closure on the container. The ultrasonic transmitter may operate at a 28 kHz frequency with a power of 5 W for 1-5 seconds. The beverage nucleator system provides for consistent nucleation of supercooled beverages without requiring a fluid or gel transmission medium.

A shelf stable liposomal based oral rehydration formulation as a mixture has an improved beverage rehydration index performance. The liposomal rehydration salt formulation prevents severe dehydration, maintains body electrolytes and fluids in a human, and rehydrates a human. The formulation includes less than 0.4% phospholipids, having an average size less than 270 nm and an osmolality of about 200 mOsm/kg.

Embodiments relate to systems and methods for therapeutic gas delivery for personal medical consumption. A hydrogen delivery system herein can include one or more electrolytic cores which use source water to carry out electrolysis-based reactions, and obtain free hydrogen (H2) gas which can be separated using a proton exchange membrane (PEM) or other filter for collection and delivery to a user. In aspects, the electrolytic core or cores can be constructed or scaled to produce a sufficient amount of hydrogen (H2) gas so that the user can ingest that gas directly, immediately, and/or in real-time or near real-time, without a need for storage of the gas. In aspects, the system can be portable, and configured with a vent port to eliminate oxygen (O2) gas that may accumulate during electrolytic reactions, and also a coalescer unit to reduce or eliminate water or water vapor from the output hydrogen (H2) gas.

Embodiments relate to systems and methods for therapeutic gas delivery for personal medical consumption. A hydrogen delivery system herein can include one or more electrolytic cores which use source water to carry out electrolysis-based reactions, and obtain free hydrogen (H2) gas which can be separated using a proton exchange membrane (PEM) or other filter for collection and delivery to a user. In aspects, the electrolytic core or cores can be constructed or scaled to produce a sufficient amount of hydrogen (H2) gas so that the user can ingest that gas directly, immediately, and/or in real-time or near real-time, without a need for storage of the gas. In aspects, the system can be portable, and configured with a vent port to eliminate oxygen (O2) gas that may accumulate during electrolytic reactions, and also a coalescer unit to reduce or eliminate water or water vapor from the output hydrogen (H2) gas.

An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.

According to embodiments, a beverage composition for human, animal, or other organism consumption includes water and protein in an amount of about 6 to about 40 grams per liter. The beverage composition has a pH of about 4.6 to about 11.0, and the beverage composition has a viscosity of about 1 to about 25 milliPascals at 5 degrees Celsius and shear rate of 100 s?1. The beverage composition is substantially free of a sweetener, a food acid, a flavoring agent, a de-foaming agent, or a combination thereof. The beverage composition is optically clear as measured by a turbidity of about 0.0001 to about 25 NTU as measured by ISO 7027-1:2016 test method.

According to embodiments, a beverage composition for human, animal, or other organism consumption includes water and a collagen protein in an amount of about 6 to about 40 grams per liter. The beverage composition has a pH of about 4.6 to about 11.0, and the beverage composition has a viscosity of about 1 to about 25 milliPascals at 5 degrees Celsius and shear rate of 100 s-1. The beverage composition is substantially free of a sweetener, a food acid, a flavoring agent, a de-foaming agent, or a combination thereof. The beverage composition is optically clear as measured by a turbidity of about 0.0001 to about 25 NTU as measured by ISO 7027-1:2016 test method.

The present invention relates to a device 1 for refining the taste of beverages 7 with an irradiation chamber 2, wherein the irradiation chamber 2 is configured to receive a beverage vessel 6, in particular a beverage glass or a beverage bottle, and at least one radiation source 9, the at least one radiation source 9 being arranged within the irradiation chamber 2 and is configured to emit a first radiation 10 with a wavelength out of a wavelength range between 270 nm and 450 nm, wherein the beverage vessel 6 is providable in the irradiation chamber 2 to be irradiated with the first radiation 10.